Rahim Asghari

458 total citations
14 papers, 359 citations indexed

About

Rahim Asghari is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Rahim Asghari has authored 14 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Rahim Asghari's work include MicroRNA in disease regulation (4 papers), Extracellular vesicles in disease (3 papers) and Nausea and vomiting management (2 papers). Rahim Asghari is often cited by papers focused on MicroRNA in disease regulation (4 papers), Extracellular vesicles in disease (3 papers) and Nausea and vomiting management (2 papers). Rahim Asghari collaborates with scholars based in Iran, Sweden and Poland. Rahim Asghari's co-authors include Jafar Rezaie, Reza Rahbarghazi‬, Leila Salimi, Nasrollah Jabbari, Tahereh Etemadi, Elinaz Akbariazar, Maryam Feghhi, Mahmoud Mahmoudi, Ali Akbari and Mahdi Ahmadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and Frontiers in Immunology.

In The Last Decade

Rahim Asghari

13 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rahim Asghari Iran 6 284 165 43 38 30 14 359
Joanne Kimiko Liu United States 3 343 1.2× 180 1.1× 49 1.1× 37 1.0× 19 0.6× 5 405
Narges Mardi Iran 10 322 1.1× 144 0.9× 59 1.4× 42 1.1× 29 1.0× 16 408
Alice Baek United States 4 451 1.6× 246 1.5× 55 1.3× 55 1.4× 30 1.0× 5 484
Daniel Levy United States 9 357 1.3× 182 1.1× 38 0.9× 33 0.9× 28 0.9× 13 392
Antje M. Zickler Sweden 6 463 1.6× 219 1.3× 54 1.3× 59 1.6× 33 1.1× 7 510
Christopher Tricarico United States 6 482 1.7× 249 1.5× 40 0.9× 96 2.5× 26 0.9× 9 535
Genevieve E. Melling United Kingdom 9 258 0.9× 150 0.9× 44 1.0× 29 0.8× 17 0.6× 9 334
Matthew Kang New Zealand 6 315 1.1× 152 0.9× 37 0.9× 47 1.2× 20 0.7× 8 349
M. Franquesa Spain 2 580 2.0× 337 2.0× 73 1.7× 56 1.5× 75 2.5× 3 608
Tuan‐Hui Chen China 2 246 0.9× 121 0.7× 43 1.0× 23 0.6× 22 0.7× 2 338

Countries citing papers authored by Rahim Asghari

Since Specialization
Citations

This map shows the geographic impact of Rahim Asghari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahim Asghari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahim Asghari more than expected).

Fields of papers citing papers by Rahim Asghari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rahim Asghari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahim Asghari. The network helps show where Rahim Asghari may publish in the future.

Co-authorship network of co-authors of Rahim Asghari

This figure shows the co-authorship network connecting the top 25 collaborators of Rahim Asghari. A scholar is included among the top collaborators of Rahim Asghari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rahim Asghari. Rahim Asghari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Mohammadian, Mahshid, et al.. (2023). Evaluation the -174G>C Genetic Polymorphism of Interleukin-6 in Iranian Patients with Chronic Lymphocytic Leukemia. Iranian journal of pathology. 18(4). 392–397. 2 indexed citations
2.
Ansari, Mohammad Hassan Khadem, et al.. (2022). Evaluation of Serum Levels of MicroRNA-200C and ACE2 Gene Expression in Severe and Mild Phases of Patients with COVID-19. Iranian Journal of Allergy Asthma and Immunology. 21(3). 254–262. 2 indexed citations
3.
Alipour, Shahriar, et al.. (2022). The role of microRNAs in COVID-19 with a focus on miR-200c. PubMed. 11. 14–23. 12 indexed citations
4.
Asghari, Rahim, et al.. (2022). Primary Burkitt lymphoma of breast presented by bilateral breast enlargement. Immunopathologia Persa. 1 indexed citations
7.
Komi, Daniel Elieh Ali, et al.. (2021). Investigation of the Molecular Mechanism of Coagulopathy in Severe and Critical Patients With COVID-19. Frontiers in Immunology. 12. 762782–762782. 12 indexed citations
9.
Komi, Daniel Elieh Ali, et al.. (2021). Investigation of p16 protein expression and its association with histopathologic parameters in breast cancer.. PubMed. 10(4). 165–170. 5 indexed citations
10.
Asghari, Rahim, et al.. (2021). Medication errors in hematology-oncology ward by consultation: The role of the clinical pharmacologist.. SHILAP Revista de lepidopterología. 12(1). 53–58. 2 indexed citations
11.
Akbari, Ali, Sina Sharifi, Mahdi Ahmadi, et al.. (2020). Free and hydrogel encapsulated exosome-based therapies in regenerative medicine. Life Sciences. 249. 117447–117447. 144 indexed citations
12.
Abbasi, Ata, et al.. (2020). Malignant Melanoma of the Nipple With Axillary Metastasis. JCO Oncology Practice. 16(8). 516–518. 5 indexed citations
13.
Rahbarghazi‬, Reza, Nasrollah Jabbari, Rahim Asghari, et al.. (2019). Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications. Cell Communication and Signaling. 17(1). 73–73. 167 indexed citations
14.
Dolatkhah, Roya, et al.. (2019). Breast cancer distribution in East Azerbaijan, Iran: Results of population-based cancer registry. Annals of Oncology. 30. ix4–ix4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026